Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Study on the Mechanism of Radiotherapy-elicited Immune Response

NCT06393140 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT06393140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06393140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Study on the Mechanism of Radiotherapy-elicited Immune Response
Lead sponsor
Fudan University
Phase
Observational
Overall status
Recruiting
Start date
July 1, 2022
Completion date
July 31, 2026
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal carcinoma salivary gland type, radiotherapy